I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 13 studies | 35% ± 13% | |
| connective tissue cell | 4 studies | 28% ± 3% | |
| adventitial cell | 4 studies | 35% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 13 studies | 35% ± 13% | |
| connective tissue cell | 4 studies | 28% ± 3% | |
| adventitial cell | 4 studies | 35% ± 7% |
Insufficient scRNA-seq data for expression of PDGFRL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 2058.93 | 651 / 653 | 94% | 83.81 | 567 / 605 |
| breast | 99% | 3593.56 | 455 / 459 | 93% | 38.14 | 1035 / 1118 |
| ovary | 100% | 2424.26 | 180 / 180 | 88% | 21.82 | 377 / 430 |
| uterus | 95% | 1111.11 | 162 / 170 | 48% | 11.41 | 222 / 459 |
| pancreas | 59% | 282.65 | 195 / 328 | 83% | 20.93 | 148 / 178 |
| lung | 44% | 293.17 | 254 / 578 | 73% | 15.81 | 840 / 1155 |
| skin | 79% | 799.65 | 1430 / 1809 | 33% | 5.82 | 157 / 472 |
| adipose | 99% | 2507.43 | 1191 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 1273.60 | 1303 / 1335 | 0% | 0 | 0 / 0 |
| prostate | 45% | 329.97 | 110 / 245 | 51% | 5.45 | 256 / 502 |
| bladder | 52% | 303.62 | 11 / 21 | 36% | 6.83 | 180 / 504 |
| esophagus | 59% | 735.02 | 859 / 1445 | 21% | 2.84 | 38 / 183 |
| muscle | 79% | 518.26 | 636 / 803 | 0% | 0 | 0 / 0 |
| intestine | 53% | 484.28 | 513 / 966 | 19% | 3.31 | 98 / 527 |
| heart | 67% | 449.62 | 578 / 861 | 0% | 0 | 0 / 0 |
| stomach | 39% | 451.16 | 139 / 359 | 26% | 3.66 | 73 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 42% | 5.92 | 19 / 45 |
| adrenal gland | 13% | 58.67 | 34 / 258 | 18% | 2.48 | 41 / 230 |
| brain | 8% | 29.48 | 205 / 2642 | 14% | 2.33 | 102 / 705 |
| kidney | 7% | 37.79 | 6 / 89 | 15% | 3.34 | 136 / 901 |
| liver | 0% | 0 | 0 / 226 | 8% | 1.22 | 33 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.23 | 1 / 29 |
| spleen | 1% | 2.33 | 2 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 3.41 | 7 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0008150 | Biological process | biological_process |
| GO_0035791 | Biological process | platelet-derived growth factor receptor-beta signaling pathway |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005019 | Molecular function | platelet-derived growth factor beta-receptor activity |
| GO_0004992 | Molecular function | platelet activating factor receptor activity |
| Gene name | PDGFRL |
| Protein name | Platelet-derived growth factor receptor-like protein (PDGFR-like protein) (PDGF receptor beta-like tumor suppressor) Platelet derived growth factor receptor like |
| Synonyms | PRLTS |
| Description | |
| Accessions | A0A669KBD1 ENST00000673645.1 Q15198 ENST00000251630.11 ENST00000541323.1 |
